- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 213/70 - Sulfur atoms
Patent holdings for IPC class C07D 213/70
Total number of patents in this class: 327
10-year publication summary
|
13
|
27
|
24
|
19
|
17
|
16
|
18
|
20
|
9
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Chemical Company, Limited | 8988 |
17 |
| Bristol-myers Squibb Company | 4863 |
10 |
| Takeda Pharmaceutical Company Limited | 2943 |
8 |
| BASF SE | 20432 |
6 |
| LG Chem, Ltd. | 17639 |
6 |
| Mitsui Chemicals Agro, Inc. | 91 |
6 |
| Ardea Biosciences, Inc. | 76 |
6 |
| Neurocrine Biosciences, Inc. | 400 |
6 |
| Southern Research Institute | 211 |
6 |
| Genentech, Inc. | 3869 |
5 |
| Astellas Pharma Inc. | 1125 |
5 |
| Celgene Quanticel Research, Inc. | 167 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 862 |
5 |
| Inventisbio Co., Ltd. | 65 |
5 |
| Syngenta Participations AG | 3032 |
4 |
| Curis, Inc. | 129 |
4 |
| Ishihara Sangyo Kaisha, Ltd. | 660 |
4 |
| Kotobuki Pharmaceutical Co., Ltd. | 39 |
4 |
| Nihon Nohyaku Co., Ltd. | 315 |
4 |
| Nippon Soda Co., Ltd. | 883 |
4 |
| Other owners | 207 |